OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

۱ دقیقه مطالعهمتن اصلی

OpenAI is acquiring Orchestra Bio to bring AI powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Read the full post on OpenAI News →

منتشرشده در

OpenAI News

خواندن در منبع

ادامه مطالعه